Glacier FarmMedia Response to COVID-19

Canada could be last to ratify CUSMA deal, Trudeau says

Ottawa | Reuters — Canada could be the last of the three North American countries to ratify a new trade deal, Prime Minister Justin Trudeau said on Tuesday, indicating that his plan to match the U.S. timetable was set to fail.

Trudeau’s Liberal government said from the start it wanted to work in tandem with Washington to formally approve the U.S.-Mexico-Canada Agreement (CUSMA), which was signed last year.

The United States, Mexico and Canada agreed last week to revised terms for CUSMA to replace the 1994 North American Free Trade Agreement.

Mexico has already ratified the deal and the U.S. House of Representatives will consider legislation on Thursday to implement the pact, a senior Democrat said. The House ways and means committee approved the revised pact by voice vote on Tuesday,

Canadian legislators, however, are not due back from a winter break until Jan. 27. The Liberals lost their majority in an October election and must work more closely with opposition parties to push through legislation.

“We might — because of our parliamentary calendar — be the last parties to ratify, so we’re going to have to try to get to it as quickly as we can,” Trudeau told Toronto’s Citytv.

Trudeau said he was reasonably confident his government would find enough votes to approve the treaty.

Eleanore Catenaro, a spokeswoman for Trudeau, said Ottawa still wanted to work with the United States as much as possible on ratification. She declined to say whether Trudeau might call lawmakers back to work ahead of schedule in January.

Canada’s two main opposition parties suggested last week they could move to delay ratification, accusing the Liberal government of botching revisions to the treaty.

Reporting for Reuters by David Ljunggren and David Lawder.

Tagged , , , , , , ,
COPA Medallion COPA finalist in 2012, 2014 and 2015.
©2020 AGCanada is a production of Glacier FarmMedia Limited Partnership. Any affiliated or third party content is the property of its respective owner and is used with permission.
Please refer to Copyright Page for details.
Click here to view our Website Terms of Use.